Related Articles
As needed ICS/formoterol: not all of Europe is equal
Current licensing of single agent maintenance and reliever therapy ignores the evidence and has led to inequity across Europe https://bit.ly/4d7j88U
Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
Background and ObjectivesThe diagnosis of multiple sclerosis (MS) can be challenging in clinical practice because MS presentation can be atypical and mimicked by other diseases.…
Huge SF office to go from tech stalwart to tech startup
Fresh off a $1 billion influx, an SF-based AI startup is taking over a huge office.
Epacadostat Plus Preoperative Chemoradiation Is Feasible in Locally Advanced Rectal Cancer
Haeseong Park, MD, MPH, discusses findings from a phase 1 study of epacadostat with preoperative chemoradiation in locally advanced rectal cancer.
Clover Health selling AI tool to payers, providers
Clover Health’s newly formed subsidiary lists five provider groups and technology companies as existing customers.
Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
World-first tooth-regrowing drug will be given to humans in September
The world’s first human trial of a drug that can regenerate teeth will begin in a few months, less than a year on from news…
Fort Lauderdale’s U.S. 1 tunnel to reopen all 4 lanes Friday after makeover that began in 2021
A project that was supposed to take two years is taking almost three. Work began 32 months ago, bringing detour after detour for commuters making…
Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes
Public-private collaboration aims to take ALS therapies beyond ‘a shot in the dark’
In 2015, after spending nearly four decades grinding his way up the ladder at one of the world’s most prolific construction equipment companies, Ed Rapp…